Louvain-La-Neuve, Belgium, 28 April 2017 - IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of proton therapy solutions for the treatment of cancer, today announces that it has signed a contract with the Children's Cancer Hospital Foundation Egypt (CCHF), a leading NGO in Egypt, to install a Proteus®ONE* compact proton therapy solution at Hospital 57357 (CCHE) in Cairo.

This contract covers the delivery of a Proteus®ONE solution, including the latest generation Pencil Beam Scanning, isocenter volumetric imaging (Cone Beam CT) capabilities and a long-term maintenance agreement. The hospital plans to start treating patients by 2020. The typical end-user price for a Proteus®ONE system with a maintenance contract is between EUR 35 and 40 million. This will be IBA's 19th installation of the compact single-room proton therapy solution.

Olivier Legrain, Chief Executive Officer of IBA, commented: "Due to the precise nature of its delivery, proton therapy is particularly appropriate for the treatment of children. Children with tumors in the brain, head, neck, spinal cord, lungs, etc., can benefit from this treatment because protons deposit the majority of their energy within a controlled zone while limiting the impact on healthy tissue that surrounds the tumor. The Children's Cancer Hospital Foundation Egypt and Hospital 57357's philosophy and ambition of providing children with cancer access to the most advanced radiation therapy technology is creditable; we're pleased to partner with CCHF and CCHE and to be installing the first proton therapy solution in Africa."


Prof Sherif Abouelnaga, Chief Executive Officer of Children's Cancer Hospital Egypt 57357, commented: "Our mission is to provide the best comprehensive family-centered quality care and a chance to cure all children with cancer, free of charge and without discrimination. We are excited to partner with IBA to bring the world's leading proton beam therapy equipment to cancer patients in Egypt for the first time. Our vision and ambition is to become the center of excellence in radiotherapy for Africa and the Middle East."


About Proteus®ONE
Proteus®ONE is the compact intensity modulated proton therapy (IMPT) solution from IBA. It benefits from the latest technologies developed with renowned clinical institutions. Proteus®ONE is smaller, more affordable, easier to install and to operate. It is ultimately easier to finance, making this advanced radiation therapy modality available to more institutions and patients worldwide.

Rad Oncology Homepage